



To the Editor: We read with interest the article by Bomback
et al.1 reporting increased frequency of hyperuricemia and
chronic kidney disease (CKD) among persons with increased
sugar-sweetened soda consumption.
However, we wish to note a number of methodological
shortcomings. First, the authors did not consider the
medications that can alter serum uric acid (UA) level,
including low-dose aspirin, angiotensin-converting enzyme
inhibitors, angiotensin receptor blockers, fenoﬁbrate, and
thiazide diuretics.2 We also do not know about some
concomitant medical disorders that may cause elevated UA
level, such as pseuriasis, multiple sclerosis, Parkinson’s, and
cardiovascular disease.3
Second, we do not know how many of these hyperuricemic
patients developed gout disease and received allopurinol or
other uricosuric drugs. Third, the authors reported only
laboratory creatinine value as evidence of UA-associated CKD.
However, during such a long observation period, many of these
patients may have had alternative reasons for their reduced
glomerular ﬁltration rate values other than hyperuricemia.
Again, it is known that CKD can cause elevated serum UA level
per se; thus, it is difﬁcult to say whether CKD is secondary to
hyperuricemia or vice versa. Lastly, the authors did not state the
speciﬁc laboratory method by which they studied serum UA
level. They used cutoff values primarily based on the literature,
which we think are inappropriate, because we do not know
their laboratory cutoff for hyperuricemia.
To reach a decision that might affect the lifestyle of many
people, the authors might have controlled for most, if not all,
of the confounding variables that affect UA level other than
sugar-sweetened soda.
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The Authors Reply: We agree with the comments by Solak
et al.1 on the importance of adjusting, if possible, for
medications and co-morbid conditions that can affect uric acid
and creatinine levels. Indeed, we identify this limitation
ourselves in the discussion of our results2 and acknowledge
that the lack of such detailed information is an inherent
shortcoming of any observational analysis. Thus, we are
empowered to speak only of associations rather than causation.
We disagree with their comments about deﬁnitions
used for chronic kidney disease (CKD) and hyperuricemia.
As stated in the discussion and published online in
supplementary tables, we used alternative deﬁnitions of
CKD based on changes in serum creatinine, estimated
glomerular ﬁltration rate, and urinary albumin excretion;
the lack of association remained. Sex-speciﬁc cutoff points for
hyperuricemia that are lower than conventional, gender-
neutral cutoff points allow for a more sensitive deﬁnition of
hyperuricemia and should theoretically provide a greater
likelihood of detecting an association between exposure and
outcome. In addition, supplementary analyses treating uric
acid outcomes as a continuous variable failed to show an
association between sugar-sweetened beverage consumption
and any change in uric acid levels.
Finally, we do not think it is prudent for the associations
drawn from any single epidemiologic analysis, including ours,
‘to affect the lifestyle of many people,’ as Solak et al.1 assert. We
reiterate that our ﬁndings do not justify unrestrained
consumption of sugar-sweetened sodas by individuals with or
without hyperuricemia or CKD. Rather, we intend the results
from our longitudinal analyses in this and other cohorts3
to add new, objective information to the still-growing body of
literature surrounding the potential health consequences of
sugar-sweetened soda.4 We hope that the scrutiny paid to our
‘negative’ study by Solak et al.,1 as well as by Curhan and
Forman5 in their accompanying editorial, is applied equally to
past, present, and future ‘positive’ studies on this subject. We
agree with Curhan and Forman’s ﬁnal suggestion to readers
(and their patients) that sugar-sweetened beverages should be
avoided, but we disagree that the evidence for beneﬁt from such
behavior is ‘overwhelming’ with regard to kidney function.
1. Solak Y, Karagoz A, Atalay H. Sugar-sweetened soda consumption,
hyperuricemia, and kidney disease. Kidney Int 2010; 78: 708.
2. Bomback AS, Derebail VK, Shoham DA et al. Sugar-sweetened soda
consumption, hyperuricemia, and kidney disease. Kidney Int 2010; 77:
609–616.
3. Bomback AS, Katz R, He K et al. Sugar-sweetened beverage consumption
and the progression of chronic kidney disease in the Multiethnic Study of
Atherosclerosis (MESA). Am J Clin Nutr 2009; 90: 1172–1178.
4. Johnson RJ, Segal MS, Sautin Y et al. Potential role of sugar (fructose) in the
epidemic of hypertension, obesity and the metabolic syndrome, diabetes,
kidney disease, and cardiovascular disease. Am J Clin Nutr 2007; 86:
899–906.
5. Curhan GC, Forman JP. Sugar-sweetened beverages and chronic disease.
Kidney Int 2010; 77: 569–570.
Andrew S. Bomback1, Vimal K. Derebail2 and
Abhijit V. Kshirsagar2
1Division of Nephrology, Department of Medicine, Columbia University
College of Physicians and Surgeons, New York, New York, USA and
l e t te r to the ed i to r http://www.kidney-international.org
& 2010 International Society of Nephrology
708 Kidney International (2010) 78, 708–711
